Stocks
Nektar Therapeutics (NKTR) EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -325.5 | -323.9 | -243.1 | -86.7 | -129.7 | -123.0 | ||
| Changes by years, y/y, % | -30% | 0% | -25% | -64% | +50% | -19.9% | |||
Nektar Therapeutics. EBITDA US GAAP, bln rub
Nektar Therapeutics. EBITDA US GAAP, changes, %
Nektar Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Nektar Therapeutics (NKTR) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA, bln rub | ? | 17.5 | -41.0 | -33.8 | -29.3 | -18.9 | -123.0 | |
| Changes by years, y/y, % | -152% | +38% | -24% | -2% | -208% | |||
| Changes by quarters, q/q, % | -158% | -334% | -18% | -13% | -36% | |||
